Trulieve Cannabis Corp.
- TRLV · NYSE
- Medicinal Chemicals & Botanical Products
- Tallahassee, FL
- 5,000 employees
- CIK 0001754195
Updated from SEC filings through
Top things to know
Executives
-
Kim A. Rivers Chairman and CEO 4, 2026-06-26 -
Jan Reese Chief Financial Officer 4, 2026-03-17 - Brett R. Walsh Chief Accounting Officer 4, 2026-03-17
- Eric Powers Chief Legal Officer 4, 2026-03-17
- Kyle Landrum Chief Production Officer 4, 2026-03-17
- Jason Pernell President 4, 2026-03-17
What leadership is saying
“State licensed medical marijuana rescheduling unlocked major milestones including DEA registration, removal of 280E tax, and uplisting to the NYSE”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
Trulieve Cannabis Corp. is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Tallahassee, FL. It trades as TRLV on NYSE. Revenue was $1.2B in the fiscal year ending December 31, 2025, -0.4% from the year before. It reported about 5,000 employees. Kim A. Rivers is Chairman and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.2B 10-K, 2026-02-26 | $1.2B 10-K, 2026-02-26 | $1.1B 10-K, 2026-02-26 | $1.2B 10-K, 2025-02-27 | $932M 10-K, 2024-02-29 |
| Operating income | $143M 10-K, 2026-02-26 | $97.8M 10-K, 2026-02-26 | -$222M 10-K, 2026-02-26 | $50.2M 10-K, 2025-02-27 | $204M 10-K, 2024-02-29 |
| SG&A | $445M 10-K, 2026-02-26 | $510M 10-K, 2026-02-26 | $386M 10-K, 2026-02-26 | $447M 10-K, 2025-02-27 | $311M 10-K, 2024-02-29 |
| Net income | -$122M 10-K, 2026-02-26 | -$161M 10-K, 2026-02-26 | -$533M 10-K, 2026-02-26 | -$253M 10-K, 2023-03-08 | $17.4M 10-K/A, 2023-04-05 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Kim A. Rivers CEO Trulieve | Chairman and CEO | 4, 2026-06-26 |
| Jan Reese | Chief Financial Officer | 4, 2026-03-17 |
| Brett R. Walsh Chief Accounting Officer at Trulieve | Chief Accounting Officer | 4, 2026-03-17 |
| Eric Powers Chief Legal Officer and Corporate Secretary at Trulieve | Chief Legal Officer | 4, 2026-03-17 |
| Kyle Landrum Chief Production Officer at Trulieve | Chief Production Officer | 4, 2026-03-17 |
| Jason Pernell | President | 4, 2026-03-17 |
| Christine Ann Hersey | Chief Corp Affairs & Strategy | 4, 2026-03-17 |
| Nilyum Jhala | Chief Technology Officer | 4, 2026-03-17 |
| Joy Malivuk | Chief Accounting Officer | 4, 2025-12-08 |
| Timothy Morey | Chief Sales Officer | 4, 2025-12-08 |
What Trulieve Cannabis Corp. does
Trulieve Cannabis Corp. is a reporting issuer in the United States and Canada. The Company’s Subordinate Voting Shares (as hereinafter defined) are listed for trading on the Canadian Securities Exchange (“CSE”) under the symbol “TRUL” and are also traded in the United States on the OTCQX Best Market (“OTCQX”) under the symbol “TCNNF”.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Public float | $600M (as of June 30, 2025) | 10-K, February 26, 2026 |
|---|---|---|
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting June 25, 2026 (filed June 25, 2026) | DEF 14A, June 25, 2026 |
| Auditor | WithumSmith+Brown, PC (New York, New York) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| June 26, 2026 | Kim A. Rivers Chairman and CEO | Sale | 136,811 | $1.2M | Form 4, June 26, 2026 |
| June 25, 2026 | Kim A. Rivers Chairman and CEO | Sale | 1,080,000 | $8.9M | Form 4, June 25, 2026 |
| June 22, 2026 | Kim A. Rivers Chairman and CEO | Sale | 482,196 | $4.5M | Form 4, June 22, 2026 |
| November 21, 2024 | Richard S. May Director | Buy | 1,610 | $10K | Form 4, August 13, 2025 |
| November 20, 2024 | Susan Thronson Director | Buy | 3,968 | $25K | Form 4, August 13, 2025 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-11
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-08-07
- Item 2.01 Completion of acquisition or disposition of assets
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-05
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-07-02
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-06-12
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-06-11
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-06-09
- Item 8.01 Other events
- 8-K filed 2026-06-04
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- 8-K filed 2026-05-07
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Trulieve Cannabis Corp.
- What does Trulieve Cannabis Corp. do?
- In its own words, from Item 1 of its 10-K: "Trulieve Cannabis Corp. is a reporting issuer in the United States and Canada. The Company’s Subordinate Voting Shares (as hereinafter defined) are listed for trading on the Canadian Securities Exchange (“CSE”) under the symbol “TRUL” and are also traded in the United States on the OTCQX Best Market (“OTCQX”) under the symbol “TCNNF”."
- What is Trulieve Cannabis Corp.'s revenue?
- $1.2B for the fiscal year ending December 31, 2025, from its 10-K filed February 26, 2026.
- Is Trulieve Cannabis Corp. profitable?
- Trulieve Cannabis Corp. reported net income of -$122M for the fiscal year ending December 31, 2025.
- How many employees does Trulieve Cannabis Corp. have?
- About 5,000 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Trulieve Cannabis Corp.?
- Kim A. Rivers, Chairman and CEO, as named in a 4 filed June 26, 2026.
- Who is the CFO of Trulieve Cannabis Corp.?
- Jan Reese, Chief Financial Officer, as named in a 4 filed March 17, 2026.
- Where is Trulieve Cannabis Corp. headquartered?
- Tallahassee, FL.
- What is Trulieve Cannabis Corp.'s stock ticker?
- TRLV on NYSE.
- What industry is Trulieve Cannabis Corp. in?
- Medicinal Chemicals & Botanical Products, SIC code 2833.
- What is Trulieve Cannabis Corp.'s website?
- trulieve.com. Investor relations: https://investors.trulieve.com.
- When does Trulieve Cannabis Corp. report earnings next?
- November 6, 2026. Source: ir_event.
- Is Trulieve Cannabis Corp. a public company?
- Yes. Trulieve Cannabis Corp. files with the SEC under CIK 0001754195 and trades as TRLV.
- Who audits Trulieve Cannabis Corp.?
- WithumSmith+Brown, PC, New York, New York, as named in its latest annual report (10-K).
- What is Trulieve Cannabis Corp.'s public float?
- $600M as of June 30, 2025, as reported on the cover of its 10-K filed February 26, 2026.
- How many business segments does Trulieve Cannabis Corp. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Trulieve Cannabis Corp.'s annual shareholder meeting?
- June 25, 2026, per its proxy statement (DEF 14A) filed June 25, 2026.
- Have Trulieve Cannabis Corp. insiders traded stock recently?
- Since November 20, 2024, officers and directors reported 3 open-market sales worth about $14.7M and 2 purchases worth about $35K on Forms 4 and 5. The most recent: Kim A. Rivers (Chairman and CEO) sold 136,811 shares on June 26, 2026.